Impact of COVID-19 on Psoriasis Practice

COVID-19 had a major impact on dermatology practice globally with special emphasis on chronic diseases e.g. psoriasis. The main objective of this work is to investigate the effect of COVID-19 pandemic on psoriasis management.

This work is designed as a cross-sectional survey based on a questionnaire directed to Egyptian dermatologists.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Psoriasis COVID-19 Coronaviridae Infections Coronavirus Infections Covid19 Infections Lung Diseases Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Skin Diseases Skin Diseases, Papulosquamous Skin and Connective Tissue Diseases Virus Diseases

Age range

25 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Mona El-Kalioby

Cairo, 11351, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Egyptian Dermatologists

Treatment and study plan

Primary outcomes

Questionnaire to assess 1) Prescription pattern for Psoriasis patients during COVID-19 2) Management pattern for Psoriasis patients during COVID-19

Time frame: 2-4 weeks
Questionnaire to assess 1) Impact of COVID-19 on the course of psoriasis in patients 2) Impact of COVID-19 on the psoriasis patients behaviour

Time frame: 2-4 weeks

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Impact of COVID-19 on Psoriasis Practice: A Cross Sectional Study

Important dates

Study start: 2020
Primary completion: 2020
Study completion: 2020
First posted: Oct 9, 2020
Registry last updated: Jan 14, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed